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Molecular recognition processes are at the basis of the development of diagnostic devices and 
applications as well as drug-receptor, antigen-antibody and many more similar interactions. 
For many years the dominance of antibodies has remained unchallenged for analytical, 
diagnostic and therapeutic applications.[1] Nonetheless, antibodies have disadvantages 
including elevated cost, immunogenicity, and poor shelf-life and stability,[2] and much 
research is directed toward the development of suitable alternatives.[3] 
Several alternatives have already been developed based on diverse materials.[3-4] For example, 
given the protein nature of antibodies, engineered binding proteins (EBPs) and fragments 
have been produced.[5] Nonetheless, despite their lower cost in comparison with antibodies, 
the stability of EBPs and their poor integration with sensing platforms still remain 
problematic.  
Another promising alternative material is nucleic acids: aptamers (from the Latin aptus - fit, 
and Greek meros - part) are oligonucleotides that bind to a specific target molecule and have 
started to represent more and more a suitable alternative to antibodies, since they can be 
manufactured on both small and large scale by automatic processes, which makes them 
     
2 
 
reasonably cost-effective.[6] In addition, they are more intrinsically stable than antibodies to 
environmental conditions (denaturation of a double-strand of DNA usually needs a 
temperature up to 95 °C).[7] Nonetheless, they tend to be susceptible to degradation by 
ubiquitous nuclease enzymes,[8] and their technology, until recently, was well covered by 
intellectual property, thus making it poorly suitable for large-scale application and 
evaluation.[3, 9]  
A third alternative to antibodies, probably not as well-known as the previous two, is 
represented by molecularly imprinted polymers (MIPs).[10] The last thirty years have seen a 
dramatic increase in the research and applications of these materials.[11] MIPs are fully-
synthetic polymeric materials produced around the target molecule (template); after the 
polymerization process, the template is washed away from the material, leaving behind 
cavities suitable to recognize and rebind the molecule again. They can be selective for both 
shape and chemical functionality.[10] Nonetheless, so far MIPs have promised much more than 
they have actually delivered, especially in terms of application, since their rebinding 
performance is often inferior to that of antibodies or aptamers.[3a]  
A better synthetic substitute might be represented by MIP nanoparticles (MIP NPs),[12] which 
better mimic their natural protein counterparts, not only in terms of rebinding performance but 
also regarding their size and dispersibility characteristics.[13] Nonetheless, even if these 
nanomaterials are more comparable and suitable to mimic the actual antibody proteins, their 
composition is still based on the same “classic” monomers which have been used for the past 
30 years to produce bulk MIPs, definitely not tailored for the specific target molecule.[10] 
Strategies like combinatorial synthetic approaches or computational modelling have advanced 
and improved the situation significantly, but a lot remains to be done.[14]  
A potential promising system might be a hybrid which integrates two or more of the 
technologies described above.[15, 16] The group of Allender et al. has already looked into 
introducing short peptide sequences into polymer matrixes in order to confer increased 
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specificity and selectivity deriving from thanks to the chemical complexity of the protein-
derived recognition element.[15b] This approach, despite being very elegant and promising, has 
been very difficult to optimize successfully. 
In our opinion, a better option might be represented by a new category of imprinted materials 
which integrate more resistant and versatile aptamer monomers inside their structure. A first 
attempt at this has been explored by Spivak et al., who have introduced aptamer strands into 
molecular imprinted hydrogels for proteins (thrombin, PDGF-ββ) or viruses particles,[16] 
which resulted in the production of materials that were able to selectively swell (or shrink) in 
the absence (or presence) of the template. However, in this work the introduction of the 
aptamer monomer was performed by modifying the aptamer sequences using 5’-phosphate 
Acrydite™ modification, which leaves the DNA strand reasonably flexible, potentially 
resulting in cross-reactivity or easier degradation. 
What we propose here is a novel and different approach, which involves the formation of 
polymerizable aptamer sequences prepared by introducing C-5 alkene-modified 2’-
deoxyuridine residues into the DNA strand, thus resulting in single to multiple covalent 
anchoring points between the aptamer and the polymer matrix. We produce MIP NPs 
imprinted for cocaine using a solid-phase imprinting and selection procedure[17] either with a 
plain classical polymerization mixture (Plain MIP NPs) as well as several modified aptamer 
(AptaMIP NPs) and control sequences, demonstrating that the MIP NPs bearing the right 
aptamer sequence cross-linked with the MIP matrix through multiple anchoring points exhibit 
the best recognition performance for the template. Moreover, we demonstrate that the 
polymer matrix protects the degradation of DNA aptamer strand from nuclease. 
The modified nucleoside monomer which has been used to develop this work is commercially 
available as phosphoramidite (Link, UK), or can be synthesized using a rapid microwave-
based palladium-catalyzed modification of 5-iodo-2’-deoxyuridine[18] (Figure 1a).  
 






































• Cocaine aptamer (T*6):
5’-GAC AAG GAA AAT* CCT* T*CA AT*G AAG T*GG GT*C-3’
• Cocaine aptamer (T*1):
5’-GAC AAG GAA AAT CCT TCA ATG AAG TGG GT*C-3’
• Cocaine aptamer with commercial AcryditeTM (AcryditeTM):
5’-Acryd-GAC AAG GAA AAT CCT TCA ATG AAG TGG GTC-3’
• Poly T 12mer (PolyT, control):







Figure 1. (a) Scheme showing the synthesis of polymerizable aptamer sequences using the 
modified Carboxy-dT-CE Phosphoramidite (T*) or the Acrydite™. (b) List of polymerizable 
DNA sequences used in this work: cocaine aptamer with one (T*1) or six (T*6) 
polymerizable residues or with a flexible 5’-terminal modification (Acrydite™). Poly T 
12mer sequence has been synthesized as a control (PolyT). 
 
The aptamer sequence chosen (5’-GAC AAG GAA AAT CCT TCA ATG AAG TGG GTC-
3’) was published for the template cocaine in 2001,[19] and since then it has been investigated 
and exploited in a number of studies.[20] This sequence exhibits a total of six thymine residues, 
which could potentially be used for substitution with the modified polymerizable monomer 
(Figure 1b).  
We decided to substitute one thymidine (T*1) or all six thymidines (T*6) to provide either 
single or multiple anchoring points with the polymer. During the oligonucleotide deprotection 
conditions, the ester group is transformed into an acrylamide. We have chosen this type of 
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modification because from our previous work other types of alkene or allyl modifications do 
not result in a sufficient incorporation level of the monomers into the polymer matrix (data 
not shown). On its own the nucleoside monomer has been already used in our group to 
perform the imprinting of 2’-deoxyadenosine nucleoside, and it has resulted in an improved 
rebinding and specific recognition performance in comparison with plain MIP NPs prepared 
using only the classical acrylamide monomers.[21] 
For comparison purposes, we have also used a commercial Acrydite™ modified aptamer 
sequence (Figure 1b), as detailed in the work of Spivak et al. as well as other authors.[16, 20a, 
20f] This modification is readily available from commercial suppliers but it might not represent 
the best option for an imprinting approach because it could confer too much flexibility to the 
aptamer sequence, thus resulting in a reduced recognition performance and poorer 
applicability for diagnostic purposes. 
In addition, to confirm that a specific aptamer sequence is required in the polymer to obtain 
the recognition, a polymerizable Poly T 12mer containing one polymerizable monomer 
residue (PolyT) has also been synthesized.  
The solid-phase MIP NPs synthesis and selection strategy used in this work involves the 
immobilization of the template onto glass beads as solid support, hence we exploited an 
EDC/NHS coupling procedure to immobilize a cocaine analogue and metabolite bearing a 
carboxylic group (benzoylecgonine, BEC) onto amino-derivatized glass beads (Figure 2). 
 
















































































Figure 2. Schematic of the synthetic protocol for the immobilization of the cocaine analogue 
template (benzoylecognine, BEC) on the glass beads surface. 
 
Specifically, the beads were previously activated in boiling NaOH solution to increase the 
number of reactive OH groups on their surface, which then facilitates the following step, 
resulting in a good coverage of the glass surface with silane containing primary amino groups 
(potentially up to 12 µmol per gram of solid phase).[22] After the silanization step, the 
activation of the carboxylic group of BEC using EDC/NHS allowed the immobilization of the 
template molecules forming an amide bond with the amino groups present on the glass beads. 
Using this strategy, the amount of BEC templates immobilized, determined 
spectrophotometrically (at λmax = 231 nm) was 0.13 µmol g-1 of glass beads. 
After washing to remove the unbound BEC, the solid-phase synthesis of MIP NPs was then 
performed in the presence of template immobilized on glass beads.[17, 23] The principle behind 
this method is summarized in Figure 3.  
 





























































































































































Figure 3. Schematic representation of the solid-phase synthesis and selection of AptaMIP 
NPs. The polymerizable sequence is incubated first with the solid phase bearing the cocaine 
analogue template (BEC). After this step the remaining classical monomers are added to the 
solid phase bearing at this point the immobilized template complexed with the aptamer DNA 
and the polymerization is initiated by the addition of APS and TEMED. In the case of Plain 
MIP NPs, the first incubation step is performed using simple PBS without any DNA aptamer. 
The low-affinity particles, as well as unreacted monomers, are washed at relatively low 
temperature using PBS (0.005 M, pH 7.4). The temperature is then increased and high-affinity 
MIP NPs are eluted from the solid phase using water. Scheme adapted from Poma et al.[17a] 
 
First, the solid phase was suspended in the aptamer monomer solution (either T*1, T*6, 
Acrydite™ or PolyT) and incubated for 1 h. This would allow correct folding of the aptamer 
sequences onto the immobilized template, thus producing a “pre-polymerization” complex 
which should then act as a polymerization center for the subsequent nanoparticle formation. 
We used a ~2-fold excess of BEC in comparison to the molar amount of aptamer; this choice 
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was dictated by the limited amount of polymerizable aptamer material available. The 
concentration of the sequences used was slightly below the range of KDs measured for this 
type of aptamer (58 µM, while the measured KDs range from 80 µM to 200 µM).[19, 20] This 
transduced into a maximum theoretical amount of aptamer-BEC complexes ranging between 
29 and 55 µM. In the case of Plain MIP NPs, the first incubation step is performed using 
simple PBS without any DNA aptamer. After the incubation, the remaining monomer solution 
composed of NIPAm, BIS, TBAm and AAc was poured in the reaction vessel and the 
polymerization process was then initiated in mild conditions by adding a redox-initiation 
system (APS and TEMED). The polymerization process used here has been extensively 
optimized and exploited by several groups for producing MIP NPs in aqueous media 
imprinted with all sorts of “delicate” structures, ranging from peptide sequences to whole 
proteins.[17, 24] This is one of the first examples in which this system has been exploited to 
imprint such a small structure like cocaine, which in this case has been chosen as a model 
template not only due to the importance of its detection in those cases of suspected drug abuse, 
but also because the aptamer sequence for its detection is very well characterized.[19, 20d] As 
the reaction proceeds, polymer formed around the template will be retained due to its affinity 
and this allows for the subsequent washing/removal of low-affinity polymer and any 
unreacted monomer (Figure 3). In this case, in addition to the temperature we exploited also 
ionic strength to perform the selection procedure on the BEC-derivatized glass beads. The 
unreacted monomers and other low-affinity materials were washed out at 20 °C using PBS, 
while the high-affinity products were ultimately eluted from the template-derivatized glass 
beads by percolating double-distilled H2O at 60 °C (Figure 3). The increase in temperature 
and the reduction in ionic strength disrupt the interactions between the immobilized target and 
the high-affinity MIP NPs, thus assisting in their elution and collection. This procedure results 
in an average yield of 37 ± 3% (w/w) of high-affinity product with respect to initial monomer 
mass (Table S2), without showing dependence on the type of polymerizable DNA sequence 
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used during the polymerization. As previously demonstrated,[17] this solid-phase imprinting 
technique is extremely convenient for the production of high-affinity MIP NPs, offering 
several advantages in comparison with classical preparation procedures:[12a] i) formation of 
highly accessible binding sites (surface imprinting);[25] ii) possible automation;[17] iii) post-
derivatization or labelling of the nanoparticles for diagnostic, stabilization or immobilization 
purposes;[23, 26] iv) recyclability of templates,[17b, 21, 24e] which is a very important aspect in this 
case due to its regulated accessibility and elevated cost (~£450 for 100 mg). In addition, MIP 
NPs can be collected as a pure fraction, free from template and monomers, in a maximum 
time of 24 h per batch, as compared to days needed with methods which rely on dialysis.[24] 
This time could potentially be reduced even more, but in this case we did not want to risk 
minimizing the incorporation of the DNA monomer inside the nanoparticles, hence we 
maintained the same polymerization times as optimized for the nucleoside monomer on its 
own.[21]  
Under these conditions the incorporation level achieved for the aptamer sequences into the 
MIP NPs ranged from 55 to 75% (w/w) of the initial feed ratio (Table 1). 
 










It is surprising that the number of the polymerizable moieties did not significantly affect the 
incorporation performance. The incorporation level was comparable whether the aptamer 
sequence was bearing a single T* or six T*. The Acrydite™ modification reached a slightly 
higher incorporation level, probably due to the higher availability and flexibility of the 
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double-bond moiety which is attached to the DNA aptamer through a spacing sequence. The 
PolyT sequence reached an even higher incorporation level, possibly due to the shorter length 
in comparison with the other DNA sequences tested (12 vs 30 nucleotides), which might 
result in an easier accessibility as well as mobility of the double-bond moiety during the 
polymerization process. Changing the monomer mixture or the polymerization conditions 
(e.g., time or monomer) might result in an increased incorporation level,[27] but in this 
instance we did not want to use excessively harsh polymerization conditions because, as we 
mentioned initially, another important aspect of this work is to demonstrate the stability of the 
DNA aptamer sequence inside the nanoparticle matrix. This stability should derive entirely 
from its covalent connections established on the newly-introduced double-bond moieties 
rather than on secondary covalent connections established because of “thymine-dimer” 
structures formed following the usage of more drastic initiation systems such as UV.[27] In 
addition, we wanted to make sure that the polymerization would take place in conditions mild 
enough to guarantee the correct folding of the DNA sequence around the template, as well as 
ensuring the obtainment of a “true” nanosystem rather than a sub-micro or microsystem.[24] 
The hybrid polymerization strategy here used has resulted in the formation of NPs of about 
10-30 nm in diameter, regular in size and spheroidal in shape (see Figure 4 for a typical TEM 
of Plain, PolyT and AptaMIP NPs T*1, T*6 and Acrydite™). 
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Figure 4. A typical TEM image of: (a) AptaMIP NPs Acrydite™; (b) AptaMIP NPs T*1; (c, 
f) AptaMIP NPs T*6; (d) PolyT MIP NPs; (e) Plain MIP NPs. All images have been taken at 
30000× magnification, except (f) which is an inset of (c) at 60000× magnification to detail the 
spheroidal shape of the MIP NPs. 
 
The presence or absence of the aptamer monomer in the preparation did not affect the size. In 
addition neither sedimentation nor visible aggregation phenomena were observed during 
storage (even after four months at 4 °C). 
Despite the similar levels of DNA monomer incorporation observed for the three aptamer 
MIP NPs, a definitive difference in rebinding performance was exhibited when the NPs were 
tested using microgravimetric analysis performed on a Stanford Research Systems QCM200 5 
MHz quartz crystal microbalance.[28] BEC template was immobilized onto the gold crystal 
surface using the same immobilization conditions exploited on the solid phase used during 
imprinting. This will ensure that the template is oriented in the same way as during production 
of the MIP NPs. Several concentrations (from of 0.125 to 2 µg mL−1) of the high-affinity 
fraction of AptaMIP NPs (T*1, T*6, Acrydite™), PolyT MIP NPs or Plain or Control NPs 
(i.e., imprinted for dC) were sequentially flowed (from the lowest to the highest 
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concentration) on the chip bearing BEC, and their binding behavior was recorded. A 
schematic representation of the QCM assay is represented in Figure 5, while the results of the 





QCM surface QCM surface
BEC BEC
Control NPs Plain MIP NPs AptaMIP NPs
 
Figure 5. Schematic representation of the binding to immobilized BEC of: (a) control NPs 
(MIP NPs imprinted for dC); (b) Plain MIP NPs; (c) AptaMIP NPs. The introduction of the 
aptamer monomer with multiple anchoring points improves the recognition performance 
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Figure 6. Rebinding to BEC surface of: (a) aptamer (on its own); (b) Control MIP NPs 
(imprinted for dC); (c) PolyT MIP NPs; (d) AptaMIP NPs T*1; (e) AptaMIP NPs Acrydite™; 
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(f) Plain MIP NPs; (g) AptaMIP NPs T*6. A typical outcome of a QCM experiment of 
Aptamer, AptaMIP NPs T*6 and Plain MIP NPs on a BEC-derivatized surface is depicted in 
(h); absorption to the template is characterized by a drop in frequency on exposure to the 
sample solution. Arrows indicate the points of injection. Concentration of all samples ranged 
from 0.125 to 2 µg mL-1. QCM measurements were performed in PBS (0.003 M, pH 7.4) at 
20 °C. Of note are the “peaks” after injection of the samples (Figure 7h). These are due to the 
relative changes in pressure during the injection process. All points are measured after system 
has stabilized in buffer after injection. Data for 6a, 6b, 6c, 6d, 6e, 6f and 6g are differences 
from original starting frequency and were calculated from these stabilized periods. Error bars 
represent ±1 SD (n = 3). 
 
The sensorgrams presented here show the ability of Plain MIP NPs and AptaMIP NPs T*6 
and Acrydite™ (Figure 6e, 6f, 6g, 6h) to recognize and bind their target specifically. 
The aptamer on its own did not exhibit any relevant binding when its rebinding performance 
was assessed using the microgravimetric platform (Figure 6a and 6h). The lack of observed 
binding by the aptamer is probably due to the sensitivity of the QCM system, with the 
aptamer itself not possessing enough mass to change the frequency, given that there will be 
limited recognition sites on the surface. The greater bulk of the MIP NP allows the system to 
register binding, by mass. Given the incorporation data (Table 1), the calculated sizing by 
TEM (Figure 4), and the identical solid-phase synthesis approach for all the MIP NPs, the 
mass and density of the MIP NPs is likely to be comparable and QCM results among them 
reflect differences in binding.  
The control NPs imprinted for dC did not show any binding (Figure 6b), demonstrating the 
effectiveness of the template specificity of the imprinting procedure. 
No binding was exhibited when PolyT MIP NPs were analyzed (Figure 6c). Indeed the 
presence of the right DNA sequence suitable to achieve the correct folding around the 
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template molecule is needed to exhibit a certain rebinding performance. Interestingly, 
AptaMIP NPs bearing only one polymerizable residue (T*1) did not exhibit any significant 
binding (Figure 6d). We hypothesize that a single polymerizable residue positioned so close 
to the aptamer sequence may lock the aptamer into an inappropriate conformation. This does 
not seem to be the case for the Acrydite™ modification (Figure 6e), which also bears a single 
double-bond but in position 5’ rather than 3’ and is connected to the aptamer sequence 
through a spacer. In this case the connection through the spacer sequence might ensure a 
better folding of the aptamer onto the template, and subsequent improved imprinting 
procedure helped by the polymer matrix. Indeed, the Plain MIP NPs imprinted for BEC 
without using any polymerizable DNA sequence also exhibited a similar rebinding 
performance (Figure 6f and 6h). In both cases (Plain MIP NPs and AptaMIP NPs Acrydite™) 
there was a total frequency drop of about 3 Hz. 
The explanation for the binding behavior of AptaMIP NPs T*1 and Acrydite™ may be 
understood in light of the aptamer structure described by Cekan et al.[29] The aptamer folds 
into three helixes, one of which (containing both 5’ and 3’ ends) forms upon binding to 
cocaine. It is possible that the higher flexibility conferred to the aptamer by the spacer 
included in the Acrydite™ modification allows the third helix to form more easily upon 
binding to cocaine, while in the case of T*1 a modification so close to the base in the absence 
of further anchoring points along the DNA sequence might hinder duplex formation or 
template binding. In any case, there is a clear influence of both the nature and site of 
polymerizable modification on the effectiveness of AptaMIP NPs synthesis with multiple 
modifications showing a clear advantage. 
Indeed, AptaMIP NPs T*6 exhibited a drop in frequency of almost 7 Hz when tested by QCM 
onto a BEC-derivatised surface (Figure 6g and 6h). A calculated apparent dissociation 
constant (KD) of 4 nM was obtained, whilst in the case of Plain and AptaMIP NPs Acrydite™, 
the KD values were respectively 13.7 nM and 26.4 nM. This confirms that the calculated 
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affinity for the target for the particles was higher than the aptamer sequence on its own, given 
by the literature as between 80 µM to 200 µM.[19, 20] These results suggest that the presence of 
multiple covalent anchoring points between the aptamer and the imprinted matrix is beneficial 
to the interaction between aptamer and target.  
It would be interesting to test whether larger templates like proteins can be exploited to 
produce AptaMIPs using the method described in this work.[16] Likewise, performing a UV 
polymerization process might result in a higher incorporation as well as rigidity of the 
polymerizable aptamer monomer and associated increase in recognition.[27] Both these aspects 
are currently under investigation. 
To assess the stability of the DNA aptamer inside the AptaMIP NPs, the T*6 and Acrydite™ 
AptaMIP NPs, which had exhibited the best rebinding performance, were incubated with 
nuclease P1, which is widely used for endonucleolytic digestion of single-stranded DNA.[30] 
After the incubation period, centrifugal ultrafiltration allowed to separate the enzyme and the 
AptaMIP NPs from the digested DNA, which was then determined spectrophotometrically (at 
λmax = 260 nm) by analyzing the washings. No DNA digestion was observed from the T*6 or 
Acrydite™ AptaMIP NPs, while under the same conditions, nearly 100% of free DNA is 
digested to single nucleotides. Thus the polymer matrix is suitable to protect the aptamer from 
enzymatic digestion. More studies are in progress to assess the stability of the AptaMIP NPs 
in other conditions. 
 
In conclusion, this paper describes the first example of solid-phase synthesis of aptamer-
imprinted polymer hybrid nanomaterials capable of molecular recognition. Specifically we 
have successfully produced MIP NPs for BEC (cocaine analogue) by exploiting a modified 
polymerizable aptamer, containing either a commercial modification at the 5’ end (AptaMIP 
NPs Acrydite™) or single or multiple C-5 alkene-modified uridine nucleotides (AptaMIP NPs 
T*1 and T*6). Nanoparticles were obtained using a solid-phase imprinting polymerization 
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strategy in which template-derivatized glass beads double as an affinity matrix for production 
as well as selection and purification of synthesized imprinted nanoparticles. 
The nanomaterials obtained are spheroidal in shape, with a size comparable to natural 
antibodies.[31] The solid-phase imprinting strategy guarantees ease of accessibility of the 
binding sites, resulting de facto in a surface-imprinting procedure. 
Plain and AptaMIP NPs recognized BEC specifically when assessed by QCM, and the best 
rebinding performance was obtained, as expected, when multiple anchoring points were 
introduced into the aptamer sequence, in the case of AptaMIP NPs T*6. Surprisingly, 
AptaMIP NPs T*1 did not exhibit any significant rebinding and further investigations are 
being undertaken to better understand the parameters defining optimal incorporation of 
polymerizable modifications in AptaMIP NPs, including the optimum site, number, flexibility 
and type of modification. Future work is also planned to assess the effect of different amounts 
of aptamer DNA included in the preparation on the size, affinity and specificity of the hybrid 
AptaMIP NPs. The use of a more sensitive detection system such as Surface Plasmon 
Resonance (e.g. Biacore ®) will be investigated for future analysis. In the early days of this 
field it is likely that an empirical process of testing several modification patterns will be 
necessary for each new aptamer sequence, to find AptaMIPs with optimal binding properties.  
Importantly, AptaMIP NPs are resistant to digestion by nuclease P1, thus confirming that the 
polymer matrix acts as a shield for the incorporated aptamer sequence. 
We believe that this approach might be further explored to potentially produce hybrid MIP-
DNA systems with improved recognition performance also for larger templates, or even with 
more complex architectures which are more suitable for diagnostic applications, such as core-
shell systems.[23, 26] The gentle polymerization conditions here used should guarantee that the 
aptamer monomers would retain their stability, potentially leading to hybrid AptaMIP NPs 
suitable for in vitro or even in vivo applications such as drug development and delivery 
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Materials: N-isopropylacrylamide (NIPAm), N,N,N',N'-tetra-methylethylenediamine 
(TEMED), ammonium persulphate (APS), acrylic acid (AAc), N,N'-methylenebisacrylamide 
(BIS), N-tert-butylacrylamide (TBAm), 3-aminopropyltriethyloxy-silane (APTES), 
benzoylecgonine tetrahydrate (BEC), cysteamine, glass beads, SPE cartridges and frits, 
toluene, methanol, acetone, zinc chloride and nuclease P1 (EC: 3.1.30.1) were purchased from 
Sigma-Aldrich (UK). Sodium hydroxide, sulfuric acid, zinc chloride, sodium acetate, acetic 
acid, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), N-hydroxysuccinimide (NHS), 
3-(N-morpholino)propanesulfonic acid (MOPS), tris(hydroxymethyl)aminomethane (TRIS) 
and phosphate buffered saline (PBS) were purchased from Fisher Scientific (UK). Ethanol 
and hydrogen peroxide were purchased from VWR (UK). Cocaine aptamer sequences bearing 
the Acrydite™ modification were purchased from Integrated DNA Technologies, Inc (USA). 
Carboxy-dT-CE Phosphoramidite and 2’-deoxycytidine (dC) were purchased from Link (UK). 
Double-distilled water (Millipore) was used for analysis. All chemicals and solvents were 
analytical or HPLC grade and were used without further purification. 
Synthesis of polymerizable oligomer and aptamer sequences (Aptamer T*1, Aptamer T*6 and 
PolyT): Oligonucleotides were synthesized under standard conditions at 1 µmol scale on an 
Applied Biosystems 394 oligonucleotide synthesizer. The oligomers were deprotected and 
released from the support by treatment with concentrated aqueous NH3 at 55 °C for 16 h. The 
solutions were concentrated to dryness, resuspended in water and desalted using NAP-10 
columns (GE Healthcare). Oligonucleotide masses were verified using a Bruker micrOTOF 
LCMS system.  
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Preparation of BEC-derivatized glass beads as affinity media: Glass beads (125 g, 75 µm 
diameter, Supelco) were activated by boiling in NaOH (1 M) for 10 min, then washed 
thoroughly with double-distilled water at 60 °C, acetone and finally dried at 80 °C. They were 
then incubated in a solution of APTES (2 %, v/v) in anhydrous toluene overnight at room 
temperature, then washed with acetone and dried under vacuum. The BEC template (10 mg) 
was activated in 1 mL MOPS buffer (0.1 M, NaCl 0.05 M, pH 6.0) by adding 5 µL EDC and 
6 mg NHS for 15 min, then this solution was diluted with PBS (0.01 M, pH 7.2) to 30 mL and 
used to incubate 45 g of APTES-derivatized glass beads overnight at room temperature (0.67 
mL solution/g glass beads). The derivatized beads were washed thoroughly with double-
distilled water and dried under vacuum. After this step the glass beads were used straight 
away for the synthesis of the MIP NPs without further storage. The amount of template 
immobilized was determined spectrophotometrically (at λmax = 231 nm) by analyzing the 
amount of BEC unbound to the glass beads and found in the washings collected from the 
immobilization step. 
Solid-phase synthesis of BEC-imprinted MIP and AptaMIP NPs: a solution (0.29 µmoles in 
2.5 mL) of each polymerizable DNA sequence in PBS (0.005 M, pH 7.4) was degassed by 
purging Ar for 10 min and then incubated for 1 h at room temperature in a 14 mL glass vial 
closed using a Teflon screw-cap and containing 5 g of template BEC-derivatized glass beads 
(0.5 mL solution/g glass beads), for a total of six polymerization vials (Plain MIP NPs, 
AptaMIP NPs Acrydite™, AptaMIP NPs T*1, AptaMIP NPs T*6, PolyT MIP NPs). This 
corresponds to a ratio of 2.24 molecules of BEC per each molecule of aptamer sequence. In 
the case of Plain MIP NPs, 2.5 mL of PBS were added to maintain the incubation conditions 
similar to the other samples. Prior to the addition of the aptamer solution, the vials containing 
the solid phase were degassed under vacuum and the air inside the vials then replaced with Ar 
(3 times). In the meantime the following monomers were dissolved in PBS (0.005 M, pH 7.4, 
50 mL): NIPAm (39 mg, 0.35 mmol, 53%), BIS (2 mg, 0.01 mmol, 2%), TBAm (33 mg, 0.26 
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mmol, 40%) and AAc (2.2 µL, 0.03 mmol, 5%). TBAm was previously dissolved in EtOH (1 
mL) and then added to the aqueous solution. The total monomer concentration was 13 mM at 
this stage. The solution was degassed under vacuum and sonication for 10 min, and then 
purged with Ar for 30 min. After this time, aliquots of 2.5 mL of solution were transferred in 
the vials previously incubated with the polymerizable DNA, thus reaching a total volume of 5 
mL and a final monomer concentration of 6.5 mM. The polymerization was started by adding 
an APS aqueous solution (50 µL, 60 mg mL-1) and TEMED (1.5 µL). The polymerization was 
then carried out at 20 °C for 20 h. After the polymerization, the contents of the vials were 
transferred into empty SPE cartridges fitted with a polyethylene frit (20 μm porosity) in order 
to perform the temperature-based affinity separation of MIP NPs. The temperature of PBS 
and the SPE cartridges was kept at 20 °C (same as the polymerization step). Washing was 
performed with 3 × 5 mL of PBS (0.005 M, pH 7.4), applying manual pressure with a syringe 
if needed. This was done in order to remove non-polymerized monomers and low-affinity 
MIP NPs. The effectiveness of the washing was verified by measuring the UV absorbance of 
washing aliquots, in order to ensure complete monomer removal as well as to quantify the 
incorporation of polymerizable DNA into the polymer matrix (by difference of the absorbance 
measured at λ = 260 nm, considering that 1 O.D. unit at that wavelength corresponds to 38.8 
µg of PolyT, 29.6 µg of T*1, 30.5 µg of T*6 or 31.2 µg of Acrydite™). Afterwards the SPE 
cartridges containing the solid phase with high-affinity MIP NPs attached were heated up to 
60 °C and eluted with 5 × 5 mL H2O at 60 °C. Control NPs have been prepared in the same 
way but using dC as template. The concentration of the nanoparticles fractions has been 
evaluated by evaporation. 
Transmission Electron Microscopy (TEM) analysis: TEM images of MIP NPs were taken 
using a JEOL JEM 1400, 120kV high contrast TEM equipped with an AMT XR60 mid-
mount digital camera (11 megapixels). Samples for the analysis have been prepared by 
depositing a drop of the MIP NPs solution, previously filtered through a 0.45 μm PTFE 
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syringe filter, on a carbon-coated TEM copper grid (300 mesh, from Agar Scientific, UK), 
blotting away the excess and leaving them to dry overnight at room temperature. 
Dynamic Light Scattering (DLS) analysis: the samples for DLS were prepared in deionized 
H2O, sonicated for 5 min, then filtered through 0.45 μm PTFE syringe filters and analyzed in 
a Quartz SUPRASIL 1.5 × 1.5 mm cuvette at 25 °C by using a Malvern Viscotek DLS 
(Malvern Instruments Ltd.) equipped with OMNISIZE 3.0 software. 
Treatment of Quartz Crystal Microbalance (QCM) crystals and surface immobilization of 
templates: QCM crystals (5 MHz Cr/Au, polished, Testbourne Ltd., UK) were cleaned by 
immersion in Piranha solution (H2SO4/H2O2, 3/1, v/v) for 5 min. Caution! This mixture is 
highly corrosive, hence extreme care is required during this process. Then they were 
thoroughly rinsed with double-distilled water and left in MeOH overnight. The 
immobilization of the templates has been performed by incubating the crystals in a solution of 
cysteamine (0.2 mg mL-1) in EtOH at 4 °C for 24 h, after which they have been washed with 
EtOH and incubated for 24 h at room temperature in a 0.5 mg mL-1 solution of BEC template 
in PBS (0.01 M, pH 7.2), previously activated in MOPS buffer (0.1 M, NaCl 0.05 M, pH 6.0) 
using EDC and NHS for 15 min (same activation as for the immobilization onto the glass 
beads). Once the immobilization was completed, the crystals were washed thoroughly with 
double-distilled water before being mounted in the QCM flowcell. Successful immobilization 
of the templates was confirmed through sessile water contact angle measurements performed 
on a Theta Optical Tensiometer (Biolin Scientific, UK). 
QCM microgravimetric analysis of aptamer and BEC-imprinted Plain and AptaMIP NPs: 
Plain MIP NPs, PolyT MIP NPs, Control NPs (imprinted for dC), plain aptamer sequence and 
AptaMIP NPs (T*1, T*6 and Acrydite™) adsorption to BEC template was monitored using a 
QCM200 5 MHz quartz crystal microbalance (Stanford Research Systems, UK).[28] The 
modified QCM chips were maintained hydrated during mounting in the QCM flowcell. MIP 
NPs solutions and running buffer were introduced using an Instech P720 peristaltic pump 
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equipped with 0.020” ID tubing (Linton Instrumentation, UK) and flowing at 0.1 μL min-1. 
The QCM chip bearing the template was first stabilized in running buffer (PBS 0.003 M, pH 
7.4) at 20 °C until the system reached a stable baseline. Affinity analysis was carried out by 
sequentially flowing each MIP NPs solution for 5 min (500 µL) and analyzing the sensor 
response for 15 min. This process was repeated over the concentration range of 0.125-2 µg 
mL−1. The apparent KDs were calculated by nonlinearly fitting the binding data to a Langmuir 
binding isotherm model using GraphPad Prism 6.0 (GraphPad Software, US) under an 
assumption that all particles in solution are spheres of defined density.[24] 
Nuclease P1 DNA digestion test of AptaMIP NPs T*6 and Acrydite™: the procedure was 
adapted from Li et al.[30] An equivalent of AptaMIP NPs T*6 or Acrydite™ containing 0.2 
mg DNA in 200 μL H2O in a 2 mL plastic tube is treated with 40 μL ZnCl2 (5 mM), 60 μL 
sodium acetate buffer (50 mM, pH 5.5) and pH 5.5, and 0.5 U (2 μL) nuclease P1 previously 
dissolved in TRIS buffer (30 mM, pH 7.5), giving a total volume of 302 μL with 1.66 U mL-1 
nuclease P1, 0.66 mM ZnCl2, and 9.93 mM sodium acetate. The tube is capped and kept for 2 
h at 37 °C before centrifugal ultrafiltration (Amicon 0.5 mL centrifugal tubes 3k MWCO; 
Fisher Scientific, UK). Two washes of 250 μL H2O each of have been performed, to obtain a 
total volume of 750-800 μL. The amount of digested DNA was determined 
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Here we present a strategy to exploit aptamers as recognition elements of molecularly 
imprinted polymeric nanoparticles (AptaMIP NPs), via a modification of the chemical 
structure of the DNA. We demonstrate that the introduction of this modified “aptamer 
monomer” results in an increase of the affinity of the produced MIP NPs, without altering 
their physical properties such as size, shape or dispersibility.  
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Figure S1. Calibration curve for the BEC template used to quantify the amount immobilized 
onto the glass beads. The concentrations range from 1.0 × 10-3 to 6.25 × 10-2 mg mL-1. The 
λmax value used was 231 nm. 
 
Table S1 Static water contact angle measurements for surface-modified QCM crystals (n = 3). 
Surface Contact angle (degrees, ± SD) 
Bare gold 76.93 ± 0.52 
Cysteamine 49.45 ± 0.40 
BEC 55.40 ± 0.70 
 
     
28 
 
Table S2 Yields and dynamic light scattering (DLS) measurements for Plain, PolyT and 
AptaMIP NPs (n = 3). 
NPs Yield (%, w/w) Diameter (nm, ± SD) 
Plain MIP 34% 19 ± 5 
PolyT MIP 36% 17 ± 1 
AptaMIP Acrydite™ 40% 15 ± 1 
AptaMIP T*1 35% 14 ± 2 
AptaMIP T*6 39% 19 ± 4 
 
